Development and validation of the CHI-CAT score: a novel tool for assessing cancer-associated venous thromboembolism risk in China.

BMC Cancer · 2025 · PMC12751137 · PMID 41466392

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Third, due to differences in patient characteristics—such as age, gender, and comorbidities—there may be significant variations in the incidence of VTE between the construction and validation groups.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.